creased airway obstruction after inhalation of 2 agonists which is sometimes as great as that Background -Patients with chronic bronchitis show a large intersubject variation found in asthma. 3 The bronchial mediators which are known to cause bronchoconstriction, in sputum rheology, tracheobronchial clearance, and reversibility of airflow mucosal oedema, mucus hypersecretion, and cough can also affect mucociliary transport, obstruction to 2 agonists. The bronchial mediators which are known to cause bron-but no information is available on the distribution and on the relationship between rechoconstriction, mucosal oedema, mucus hypersecretion, and cough can also affect versibility of airway obstruction and the impairment of tracheobronchial clearance in mucociliary transport. The aim of this study was to ascertain whether changes chronic bronchitis. [4][5][6][7] Hypothetically, patients with chronic bronin tracheobronchial clearance and sputum rheological properties in patients with chitis who have a substantial bronchodilator response might show some characteristics of chronic bronchitis were associated with a specific degree of airflow reversibility bronchial asthma such as higher values for the viscoelastic properties of sputum and greater assessed as the bronchial response to an inhaled 2 agonist (fenoterol 400 g).
Hypothetically, patients with chronic bronin tracheobronchial clearance and sputum rheological properties in patients with chitis who have a substantial bronchodilator response might show some characteristics of chronic bronchitis were associated with a specific degree of airflow reversibility bronchial asthma such as higher values for the viscoelastic properties of sputum and greater assessed as the bronchial response to an inhaled 2 agonist (fenoterol 400 g).
impairment of tracheobronchial clearance. The aim of this study was to ascertain Methods -Bronchial reversibility (percentage change in baseline forced ex-whether the degree of bronchial reversibility in patients with chronic bronchitis was associated piratory volume in one second (FEV 1 )) was measured in 26 patients with chronic with changes in tracheobronchial clearance and sputum rheological properties in two groups bronchitis on three separate occasions, at least one week apart. Tracheobronchial selected on the basis of the bronchodilator response to a agonist of more or less than clearance was evaluated by a non-invasive radioaerosol technique, and an oscillatory 15% of the baseline forced expiratory volume in one second (FEV 1 ). viscometer was used for measuring sputum apparent viscosity and elasticity. The number of coughs (productive and nonproductive coughs), the wet weight of spu-Methods tum, and its radioaerosol content were re- filled the criteria of chronic bronchitis ac-
Medicine, London
Results -The change in FEV 1 after fen-cording to the UK Medical Research Council's ) were measured using a mucus by mucociliary transport and dry bellows spirometer (Vitalograph) and peak Medical Division, coughing.
expiratory flow rate (PEFR) was measured with haling two puffs of fenoterol (400 g) from a accelerates the movement of the radioaerosol particles in the airways, modifying the physiometered dose inhaler, with a one minute interval between puffs. The bronchodilator re-logical process of the radioaerosol clearance by the ciliated system. A more useful and accurate sponse was evaluated as the percentage change in FEV 1 from the baseline value (pre-broncho-way of expressing the results is by calculating the area under the tracheobronchial clearance dilator inhalation value).
Reversibility was assessed three times in each curve (AUC) using the trapezoidal rule -a large AUC indicates slow tracheobronchial clearance patient, always on a different day from the tracheobronchial clearance measurement. In and a small AUC indicates fast tracheobronchial clearance. We divided the six hour 16 patients these assessments were carried out at monthly intervals the day before the meas-tracheobronchial clearance measurement into two periods since this is a more useful and urements of tracheobronchial clearance were conducted. In the remaining 10 patients, in accurate way of expressing the results. 16 A six hour period is sufficient to achieve complete whom only one reversibility test was carried out at the time the tracheobronchial clearance clearance of the radioaerosol in normal subjects but patients with chronic bronchitis in whom was measured, the bronchodilator response was assessed further at weekly intervals in order to mucociliary clearance is impaired require a period longer than six hours to achieve a comconfirm the previous observations. Based on the mean level of reversibility subsequently plete clearance. Since observations cannot be prolonged for more than six hours for practical assessed, the patients were divided into two groups in accordance with most of the studies reasons, the division of AUC into two periods allows the process of clearance to be followed on bronchodilator response after agonist inhalation in chronic bronchitis: 3 9 10 patients better. Hence, the tracheobronchial clearance was expressed at three different time intervals: with bronchial reversibility of <15% (group 1) and those with bronchial reversibility of 15% 0-3 hours (AUC 0-3 h), 3-6 hours (AUC 3-6 h), and 0-6 hours (AUC 0-6 h). or more (group 2). An improvement of 15% over the initial FEV 1 after the agonist chalTo avoid changes in radioaerosol deposition, tracheobronchial clearance measurements were lenge was taken as evidence of reversible airway obstruction.
11 12 done on the day after the reversibility studies when the patients were stable. In 10 patients The study was approved by the local ethics committee and all patients gave written in-measurement of their tracheobronchial clearance was carried out twice over a one year formed consent for participating in the study.
period and in one patient three times. In patients with more than one measurement of tracheobronchial clearance the results were ex-  A radioaerosol technique was used to measure pressed as the arithmetical mean.
During the tracheobronchial clearance runs tracheobronchial clearance in a non-invasive manner, as previously described in detail.
7 Each the number of coughs was recorded as well as the wet weight and the radioactive content of patient discontinued all the bronchodilator therapies six hours before the measurement of all the sputum samples. tracheobronchial clearance. The subjects inhaled 5 m polystyrene particles labelled with the radionuclide technetium-99m using a standardised procedure.
13 Radioactivity in the    Apparent viscosity and elasticity were measured lung was measured by suitably collimated anterior and posterior scintillation counters im-using a Contraves Low Shear 30 sinus viscometer at a frequency of 0.352 Hz. The spumediately after inhalation at 30 minute intervals for six hours and a final count was made at 24 tum samples produced during the first three hours of the tracheobronchial clearance obhours. The lung burden at 24 hours, expressed as percentage of the initial deposited radio-servations were studied. When more than one sample was produced the arithmetical mean activity, was taken to represent alveolar deposition (AD) -that is, the amount of radio-was obtained. In the 11 patients who underwent the tracheobronchial clearance run on two or activity deposited in the non-ciliated airways and alveoli. The initial topographical dis-three occasions during a one year period, the viscoelastic results were expressed as the tribution of the radioaerosol within the lung was assessed with a large field of view gamma arithmetical mean. camera (International General Electric) interfaced with a computer and the lung margins were delineated by a ventilatory scan with krypton-81m gas. The penetration index (PI)    Each patient collected the sputum produced was defined as the ratio of peripheral to central zone radioactivity for the radioaerosol relative during the 24 hours before the tracheobronchial clearance assessment and the amount was reto that of 81m Kr gas.
14 Tracheobronchial clearance at six hours after corded as wet weight. inhalation was expressed as the percentage of the initial tracheobronchial deposition retained at six hours and corrected for productive coughing by adding the radioactivity measured in the   The Student's t test for unpaired data was used sputum to the observed retention curve at the time when it was produced. 15 In fact, cough in the statistical analysis.
group.bmj.com on July 6, 2017 -Published by http://thorax.bmj.com/ Downloaded from clearance was slower in group 1 than in group significantly greater (p<0.05) than in group 1 (table 2) .
Results

 The mean (SE) physical characteristics, smok-  
Five patients (two in group 1 and three in ing habits, baseline lung function indices, AD and PI values are given in table 1. Fourteen group 2) of the 26 did not produce sputum during the six hour observation period. patients were current smokers and 12 had ceased smoking at least one year before the Apparent viscosity (p<0.05) and elasticity (p<0.02) were both significantly lower in group study. Both smokers and ex-smokers were matched well in groups 1 and 2.
2 than in group 1.
Discussion
 
Twelve of the 26 patients (46%) were in group The results of this study indicate that patients with chronic bronchitis who have airway re-1 and 14 (54%) in group 2. There was a trend for the observed FEV 1 pre-reversibility to be versibility of >15% of baseline FEV 1 differ from those with bronchial reversibility of <15% in higher in group 1 (1.42 (0.16) l) than in group 2 (1.09 (0.08) l) but this was not statistically having a higher number of coughs, more bronchial hypersecretion, lower sputum rheological significant. After reversibility the FEV 1 was also not significantly higher in group 1 properties, and faster tracheobronchial clearance. (1.58 (0.19) l) than in group 2 (1.34 (0.05) l). The percentage change after fenoterol was
The data relating to bronchial reversibility observed in our patients with chronic bronchitis +10.3 (0.9)% and +26.6 (2.0)%, respectively, for groups 1 and 2 (p<0.001). There was a low are in agreement with those reported by other authors in that a large proportion had a intra-patient coefficient of variation (<10%) in the bronchial reversibility test among the bronchodilator response to a 2 agonist similar to that of asthmatics. [17] [18] [19] [20] As expected, the patients included in the study.
patients had a wide range of impairment of tracheobronchial clearance and of rheological properties of the sputum. 1 2 Although the   The six hour tracheobronchial clearance results tracheobronchial clearance was markedly impaired in both groups compared with healthy are shown in table 2. The tracheobronchial group.bmj.com on July 6, 2017 -Published by http://thorax.bmj.com/ Downloaded from controls, 21 patients in group 2 cleared better contribute to the faster tracheobronchial clearance in group 2 since a significant positive than those in group 1. The AUC at the different time intervals was smaller in group 2 than in correlation has been reported between tracheobronchial clearance and sputum production in group 1, especially in the 3-6 hour period. The faster clearance of the radioaerosol in group 2 patients with chronic bronchitis. 30 These results indicate that differences in progressively increased the difference in airway radioaerosol retention between the two groups. bronchial reversibility are associated with various degrees of mucus clearance in chronic Hence the difference between groups 1 and 2 progressively increased with time, becoming bronchitis. These data are supported by the fact that inflammatory mediators are known significant in the last three hours of the six hour observation period. This difference in to influence both the mechanisms involved in tracheobronchial clearance such as mucus tracheobronchial clearance between the two groups was not attributable to differences in secretion, [31] [32] [33] ciliary activity, 34 35 coughing, [36] [37] [38] and bronchial reversibility. Further studies are the initial topographical distribution of the radioaerosol since the mean values of alveolar indicated to ascertain whether the degree of inflammation and the related mediators or the deposition and penetration index were similar in both groups.
type of cellular components are the contributing factors. Patients with bronchial reversibility of >15% coughed more and produced a larger amount of mucus with a higher radionuclide content especially at 3-6 hours, but the differences were expectoration. 22 23 It is unlikely that the differ- bronchi. 24 25 12 American Thoracic Society. ATS statements -Snowbird 
